Form 4: Humacyte Director Charles Bruce Green Buys 6,000 Shares of Common Stock

Director Charles Bruce Green of Humacyte, Inc. [HUMA] purchased 6,000 shares of common stock at an average price of $1.29 on April 8, 2025.

Summary

• On April 8, 2025, Charles Bruce Green, a director of Humacyte, Inc. (HUMA), acquired 6,000 shares of common stock.
• The purchase was made at a weighted average price of $1.29 per share, with individual prices ranging from $1.285 to $1.2891.
• Following the transaction, Green directly owns 8,400 shares of Humacyte common stock.

Sentiment

Score: 6

Explanation: A director purchasing shares is generally a mildly positive signal, suggesting confidence in the company, but the scale of the purchase is not significant enough to drastically alter sentiment.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This purchase is specific to an individual's investment decision and may not reflect broader industry trends.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Humacyte, HUMA, Charles Bruce Green, Director, Stock Purchase, Form 4, Beneficial Ownership, Common Stock